about
An Eph receptor regulates integrin activity through R-RasRoles of Eph receptors and ephrins in segmental patterningReceptor protein tyrosine kinase EphB4 is up-regulated in colon cancerThe ephrin signaling pathway regulates morphology and adhesion of mouse granulosa cells in vitroReplacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responsesEphrin-B2 is a candidate ligand for the Eph receptor, EphB6Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascadeMultiple signaling interactions of Abl and Arg kinases with the EphB2 receptorRepelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signalingMultiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampusA novel signaling intermediate, SHEP1, directly couples Eph receptors to R-Ras and Rap1ASpatio-temporally regulated expression of receptor tyrosine kinases, mRor1, mRor2, during mouse development: implications in development and function of the nervous systemMistargeting hippocampal axons by expression of a truncated Eph receptorThe effects of Eph-ephrin mutations on pre-pulse inhibition in mice.A unique substrate recognition profile for matrix metalloproteinase-2.Ligand-dependent activation of EphA4 signaling regulates the proteolysis of amyloid precursor protein through a Lyn-mediated pathway.Fibroblast growth factor receptor-mediated rescue of x-ephrin B1-induced cell dissociation in Xenopus embryosEph receptors and ephrin ligands: embryogenesis to tumorigenesis.Promiscuous and specific recognition among ephrins and Eph receptorsEmerging strategies for EphA2 receptor targeting for cancer therapeutics.UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations.Downregulation of EphA5 by promoter methylation in human prostate cancer.All roads lead to actin: the intimate relationship between TCR signaling and the cytoskeleton.Abundant expression of guidance and synaptogenic molecules in the injured spinal cord.Molecular plasticity of human melanoma cells.Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches.Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.Tumor-specific mutations in low-frequency genes affect their functional properties.EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or LeukemiaRecent advances in biomarkers and potential targeted therapies in head and neck squamous cell carcinoma.A Modified Adenovirus Vector-Mediated Antibody Screening Method Identifies EphA2 as a Cancer Target.Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers.Breakdown of interlocking domains may contribute to formation of membranous globules and lens opacity in ephrin-A5(-/-) mice.Graded and discontinuous EphA-ephrinB expression patterns in the developing auditory brainstemBiological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitmentMolecular analysis of neural crest migrationMoving beyond VEGF for anti-angiogenesis strategies in gynecologic cancerRoles of EphA2 in Development and Disease.Regulation and misregulation of Eph/ephrin expression.
P2860
Q24643888-7403FF59-AACC-47E0-A1CB-07EA2AFB8F4CQ24676243-D13E0C6B-068E-45B5-8C9F-0DDDFD65EA09Q24798176-6D16EB69-B6CF-4E7A-8334-C6B4B5A1FA35Q28117197-3F945903-2739-48FB-8005-0AC49ACE96CBQ28143168-6C18D5EA-9E42-4658-8246-5F9F68CBA4F5Q28143384-4C1582B1-F3B4-4CC0-9BD6-DAD8394AED47Q28210840-0A0D3E24-781D-4747-9703-16C85B3D5634Q28211704-0CA3D9EC-8055-40D0-A341-C3AA1DDA9181Q28258431-012174F8-701C-4180-A45F-77E478396EF3Q28504623-AE991EF6-F8A4-4D32-885E-3FCB0DB2112BQ28507307-CF489A57-70E0-4E6A-A63C-F6760510B88EQ28586613-5CA25742-A1A0-4050-BAA5-E7D1440D0D91Q28591071-E2E3EA5A-CAF6-49DC-8019-65CF0A186B87Q30405943-941FD789-A3A4-4C17-9524-CDFE8281D7BCQ30761477-F6EF9247-1902-40FE-91A8-0AFEA67A03C1Q31814817-1301530C-3948-43B1-B571-8092A6152697Q33961672-27BED8D9-989B-4B81-9604-FC9B3BC42729Q34103639-0620B9E6-69B1-4E5D-A9BF-36554201FF3EQ34150471-78C24053-3A76-4917-A9A2-77811134D54DQ34469271-D4ABE315-7C4E-4746-A881-F53AB05AEA8AQ34953306-957B41E5-0161-44FD-A879-A9C37AEF16D4Q35017605-9B150F4D-EC65-46F8-ACBE-56335487CE0FQ35076710-C00442CB-91B2-47EE-A1DC-33F1C424B68AQ35093621-CBA7BDFD-D7ED-4FBB-81AE-133A326EE6B5Q35146549-D7EE341C-B797-494E-9BCD-776D81C4DC1EQ35205410-BCEBAF96-9A8D-4C18-B4A6-2F000F4D7D33Q35221906-56446421-DA10-4666-AAE9-88B5195BACEDQ35621520-B8F84254-8EB0-41BA-8BE1-A862AE63738AQ35666005-16892137-08DC-4943-9553-3B397F9511DCQ35825299-D3BFC647-2544-4EB3-AC2F-09DF393152CFQ36372261-4AFCA360-CD1B-4676-AD30-FF7F9A91077DQ36484515-6C390EF8-A221-4153-833A-B51B6153A1C4Q36828540-76D4874E-F65D-487B-9F19-9D37D6012C5FQ36880112-CD5DF1D0-FF0D-4229-9980-91D145A3B297Q36947859-8BB2D30C-446A-4C76-96B9-30501F0A7427Q36962774-10CDDAF1-4B0D-4051-855A-865643FA80F8Q37058221-8F472FAB-A91A-42A3-8673-F71F52ABADA8Q37086837-9B149658-6F32-440A-8F2E-7D06F160CC38Q37584993-C9065432-0EC7-469C-9B57-D0B3AF1E11CBQ38008491-C11E2176-F253-4519-A729-400B49FD8395
P2860
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The Eph family of receptors
@ast
The Eph family of receptors
@en
The Eph family of receptors
@nl
type
label
The Eph family of receptors
@ast
The Eph family of receptors
@en
The Eph family of receptors
@nl
prefLabel
The Eph family of receptors
@ast
The Eph family of receptors
@en
The Eph family of receptors
@nl
P1476
The Eph family of receptors
@en
P2093
E B Pasquale
P304
P356
10.1016/S0955-0674(97)80113-5
P407
P577
1997-10-01T00:00:00Z